G

Grape King Bio Ltd
TWSE:1707

Watchlist Manager
Grape King Bio Ltd
TWSE:1707
Watchlist
Price: 155 TWD 0.65% Market Closed
Market Cap: 23B TWD
Have any thoughts about
Grape King Bio Ltd?
Write Note

Grape King Bio Ltd
Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Grape King Bio Ltd
Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash CAGR 3Y CAGR 5Y CAGR 10Y
G
Grape King Bio Ltd
TWSE:1707
Cash
NT$2B
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
14%
Maxigen Biotech Inc
TWSE:1783
Cash
NT$189.3m
CAGR 3-Years
-3%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Maywufa Co Ltd
TWSE:1731
Cash
NT$41.8m
CAGR 3-Years
-25%
CAGR 5-Years
-10%
CAGR 10-Years
-8%
Chlitina Holding Ltd
TWSE:4137
Cash
NT$3.5B
CAGR 3-Years
-3%
CAGR 5-Years
6%
CAGR 10-Years
5%
No Stocks Found

Grape King Bio Ltd
Glance View

Market Cap
23B TWD
Industry
Consumer products

Grape King Bio Ltd. engages in the production and sale of pharmaceutical preparations, patent medicine, liquid tonics, drinks, and healthy food. The company is headquartered in Taoyuan, Taoyuan. The firm operates through three business segments. The Direct Sales segment is engaged in the development and manufacture of related products for subsidiaries. The Distribution segment is engaged in the provision of own-brand products. The Original Equipment Manufacturer (OEM) segment is engaged in the OEM business in Taiwan and Shanghai. The main products include lactic acid bacteria products and other healthcare products, as well as beverage products, medicines and cosmetics. The firm operates in Taiwan, mainland China and other markets.

Intrinsic Value
201.27 TWD
Undervaluation 23%
Intrinsic Value
Price
G

See Also

What is Grape King Bio Ltd's Cash?
Cash
2B TWD

Based on the financial report for Jun 30, 2024, Grape King Bio Ltd's Cash amounts to 2B TWD.

What is Grape King Bio Ltd's Cash growth rate?
Cash CAGR 10Y
14%

Over the last year, the Cash growth was -4%. The average annual Cash growth rates for Grape King Bio Ltd have been 4% over the past three years , 10% over the past five years , and 14% over the past ten years .

Back to Top